chrX-13761143-A-G
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The ENST00000340096.11(OFD1):āc.2319A>Gā(p.Pro773=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000373 in 1,207,994 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
ENST00000340096.11 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OFD1 | NM_003611.3 | c.2319A>G | p.Pro773= | synonymous_variant | 17/23 | ENST00000340096.11 | NP_003602.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OFD1 | ENST00000340096.11 | c.2319A>G | p.Pro773= | synonymous_variant | 17/23 | 1 | NM_003611.3 | ENSP00000344314 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000899 AC: 1AN: 111239Hom.: 0 Cov.: 22 AF XY: 0.0000299 AC XY: 1AN XY: 33445
GnomAD3 exomes AF: 0.0000654 AC: 12AN: 183505Hom.: 0 AF XY: 0.0000883 AC XY: 6AN XY: 67937
GnomAD4 exome AF: 0.0000401 AC: 44AN: 1096755Hom.: 0 Cov.: 31 AF XY: 0.0000359 AC XY: 13AN XY: 362117
GnomAD4 genome AF: 0.00000899 AC: 1AN: 111239Hom.: 0 Cov.: 22 AF XY: 0.0000299 AC XY: 1AN XY: 33445
ClinVar
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | OFD1: BP4, BP7, BS2 - |
Familial aplasia of the vermis;C1510460:Orofaciodigital syndrome I Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 06, 2022 | - - |
Retinal dystrophy Benign:1
Likely benign, criteria provided, single submitter | research | Dept Of Ophthalmology, Nagoya University | Oct 01, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at